These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 77361)

  • 1. Larynx cancer: a therapeutic policy at the Madras Cancer Institute.
    Rangakumar G; Shanta V
    J Surg Oncol; 1978; 10(3):183-9. PubMed ID: 77361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of integrated management of supraglottic carcinoma.
    Fu KK; Eisenberg L; Dedo HH; Phillips TL
    Cancer; 1977 Dec; 40(6):2874-81. PubMed ID: 412582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of laryngeal edema after partial laryngectomy and radiotherapy in supraglottic cancer.
    Oksüz DC; Uzel O; Yildirim A; Yetmen O; Sahinler I; Turkan S
    J Otolaryngol Head Neck Surg; 2008 Oct; 37(5):681-8. PubMed ID: 19128676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilemma of delayed radiation injury of the larynx.
    Calcaterra TC; Stern F; Ward PH
    Ann Otol Rhinol Laryngol; 1972 Aug; 81(4):501-7. PubMed ID: 4626646
    [No Abstract]   [Full Text] [Related]  

  • 5. [Radiotherapy in carcinoma of the larynx (author's transl)].
    Tsyganov AI
    Ann Otolaryngol Chir Cervicofac; 1980; 97(7-8):591-5. PubMed ID: 7469288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laryngeal complications following radiotherapy of laryngeal cancer].
    Kotaka S; Mashima K; Naka H; Watanabe I; Horiuchi J; Shibuya H
    Nihon Gan Chiryo Gakkai Shi; 1985 May; 20(4):723-7. PubMed ID: 4056546
    [No Abstract]   [Full Text] [Related]  

  • 7. The enigma of post-radiation oedema and residual or recurrent carcinoma of the larynx and pyriform fossa.
    Bahadur S; Amatya RC; Kacker SK
    J Laryngol Otol; 1985 Aug; 99(8):763-5. PubMed ID: 4020272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Laryngectomy as a salvage procedure of the patients with massive postradiation injury of the larynx].
    Piotrowski SM
    Otolaryngol Pol; 2007; 61(3):243-53. PubMed ID: 17847776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy for stage I and II laryngeal cancer using 10 MV X-rays or cobalt-60 gamma-rays.
    Hayakawa K; Mitsuhashi N; Tamaki Y; Takahashi M; Honjo J; Kamei T; Koyama I; Niibe H
    Radiat Med; 1992; 10(5):199-205. PubMed ID: 1438927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric predictors of laryngeal edema.
    Sanguineti G; Adapala P; Endres EJ; Brack C; Fiorino C; Sormani MP; Parker B
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):741-9. PubMed ID: 17398024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy of cancer of the larynx.
    Lederman M
    J Laryngol Otol; 1970 Sep; 84(9):867-96. PubMed ID: 5471893
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose response in radiotherapy for glottic carcinoma.
    Karim AB; Snow GB; Hasman A; Chang SC; Keilholtz A; Hoekstra F
    Cancer; 1978 May; 41(5):1728-32. PubMed ID: 417795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.
    Ijichi K; Hanai N; Kawakita D; Ozawa T; Suzuki H; Hirakawa H; Kodaira T; Murakami S; Hasegawa Y
    Jpn J Clin Oncol; 2014 Nov; 44(11):1063-9. PubMed ID: 25187666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of relevant factors causing postoperative recurrence of laryngeal cancer after partial laryngectomy].
    Liu C; Xu ZG
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):377-81. PubMed ID: 24054016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary radiotherapy for carcinoma in situ and early invasive carcinoma of the glottic larynx.
    Sung DI; Chang CH; Harisiadis L; Rosenstein LM
    Int J Radiat Oncol Biol Phys; 1979 Apr; 5(4):467-72. PubMed ID: 110752
    [No Abstract]   [Full Text] [Related]  

  • 16. The enigma of post-radiation edema and recurrent or residual carcinoma of the larynx.
    Ward PH; Calcaterra TC; Kagan AR
    Laryngoscope; 1975 Mar; 85(3):522-9. PubMed ID: 1121225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected radiation laryngeal necrosis after carbon ion therapy using conventional dose fractionation for laryngeal cancer.
    Demizu Y; Fujii O; Nagano F; Terashima K; Jin D; Mima M; Oda N; Takeuchi K; Takeda M; Ito K; Fuwa N; Okimoto T
    Jpn J Clin Oncol; 2015 Nov; 45(11):1076-81. PubMed ID: 26355161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
    Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
    Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
    Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
    Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Laryngeal cancer in Finland].
    Grénman R; Koivunen P; Minn H
    Duodecim; 2015; 131(4):331-7. PubMed ID: 26237923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.